Gary Gilliland, M.D., Ph.D. is the President and Director, Fred Hutchinson Cancer Research Center (FHCRC) and in an opinion piece published at the beginning of this month, writes:
“I’ve gone on record to say that by 2025, cancer researchers will have developed curative therapeutic approaches for most if not all cancers.”
I pray he is right !
He's done this sort of thing before:
healthnewsreview.org/2015/0...
"Dr. Gilliland’s comments, made at a conference packed with investors and on a financial news network, seem to be targeted primarily at Wall Street. And Wall Street’s opinion must be of considerable interest to the management at Fred Hutch, which holds a stake in Juno reportedly valued at $153.6 million when the company went public last December. According to the Seattle Times, Fred Hutch stands to receive an additional $375 million in so-called “success payments” pegged to Juno’s market capitalization. That capitalization is determined by how richly investors value Juno’s stock, which in turn may be influenced by talk of imminent cancer cures.
"But while Gilliland may be speaking to Wall Street, his comments will doubtlessly also draw the attention of patients and families desperate for new treatments — either for cancers they have now or are at risk of developing in the near future."
-Patrick
Hell, they can't cure the common cold.
New guidelines to prevent skeletal events in metastatic prostate cancer
MRI prior to HDR Brachy and HDR intensity.
